Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...

New Phase II/III study will evaluate ivonescimab plus chemotherapy against existing immunotherapy-based treatments, building ...

The IMPACT31 trial will enrol 90 high-risk liver cancer patients across the US and Asia-Pacific to evaluate GNOS-PV02 ...

New CAS Connections integration combines over 150 years of curated scientific knowledge with CAS Newton’s agentic AI ...

Medical device makers went digital to stay audit-ready. Yet their device history records are still being stitched together by ...

NeuroXT Inc., a medical device manufacturer, announced that NEXT-Cue, its AI-based Software as a Medical Device (SaMD) ...

ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asia ...

Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone ...

Operating profit reaches KRW 640 billion as Plant 5 ramp-up and US operations strengthen performance, prompting the CDMO ...

The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...

Oracle announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible ...

Filled marks show published items; half marks show documents announced or scheduled but not yet public. The device column is ...